BridgeBio Oncology Therapeutics, Inc.

US$2.04As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BBOTHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR (45.33%)
Div yield —
ROE (81.92%)
Biotechnology
Beta (5Y) 0.85
PE TTM —
TSR TTM (82.91%)
Mkt cap US$163.6M
ROIC (55.27%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.46
20.64%
134.50%
Hold 9|1|5|4|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.04
0.05
0.05
25.42%
18.64%
17.79%
9.51%
Revenue$M
19.58
20.53
20.05
19.91
5.68%
10.22%
6.16%
6.36%
Peers (US$163.6M)
Cap (US$)
PE
165.9M
—
161.1M
—
Capital
TTM
5Y
10Y
Leveragex
0.556
0.322
0.261
EBIT/Intx
0.739
0.377
0.259
Own earn%
182.81
18.12
27.02
Sh yield%
52.75
15.24
9.12
Owners
Insiders/Inst%
8.00
63.92
Short interest%
1.03
SBC / revenue%
5.72
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
0–3
$1 testx
0.0
Incr. ROIC%
11